443 related articles for article (PubMed ID: 16612060)
1. Economic evaluation of the familial cancer programme in Western Australia: predictive genetic testing for familial adenomatous polyposis and hereditary non-polyposis colorectal carcinoma.
Breheny N; Geelhoed E; Goldblatt J; Ee H; O'Leary P
Community Genet; 2006; 9(2):98-106. PubMed ID: 16612060
[TBL] [Abstract][Full Text] [Related]
2. [Hereditary colorectal carcinoma: predictive diagnosis and genetic counseling].
Mangold E; Friedl W; Propping P
Praxis (Bern 1994); 2001 Mar; 90(12):490-6. PubMed ID: 11324308
[TBL] [Abstract][Full Text] [Related]
3. [Familial colorectal cancer].
Sunde LE; Bülow S; Bernstein IT
Ugeskr Laeger; 2006 Jun; 168(24):2369-73. PubMed ID: 16822423
[TBL] [Abstract][Full Text] [Related]
4. Hereditary colorectal cancer syndromes: familial adenomatous polyposis and lynch syndrome.
Al-Sukhni W; Aronson M; Gallinger S
Surg Clin North Am; 2008 Aug; 88(4):819-44, vii. PubMed ID: 18672142
[TBL] [Abstract][Full Text] [Related]
5. Familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC): a review of clinical, genetic and therapeutic aspects.
Soravia C; Bapat B; Cohen Z
Schweiz Med Wochenschr; 1997 Apr; 127(16):682-90. PubMed ID: 9140167
[TBL] [Abstract][Full Text] [Related]
6. Inherited susceptibility to colorectal cancer.
Rowley PT
Annu Rev Med; 2005; 56():539-54. PubMed ID: 15660526
[TBL] [Abstract][Full Text] [Related]
7. Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.
Schofield L; Goldblatt J; Iacopetta B
Rural Remote Health; 2011; 11(4):1836. PubMed ID: 22188021
[TBL] [Abstract][Full Text] [Related]
8. The use of genetic testing in hereditary colorectal cancer syndromes: genetic testing in HNPCC, (A)FAP and MAP.
Ramsoekh D; van Leerdam ME; Tops CM; Dooijes D; Steyerberg EW; Kuipers EJ; Wagner A
Clin Genet; 2007 Dec; 72(6):562-7. PubMed ID: 17922849
[TBL] [Abstract][Full Text] [Related]
9. Simple and complex genetics of colorectal cancer susceptibility.
Baglioni S; Genuardi M
Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):35-43. PubMed ID: 15264271
[TBL] [Abstract][Full Text] [Related]
10. Awareness of genetic testing for colorectal cancer predisposition among specialists in gastroenterology.
Batra S; Valdimarsdottir H; McGovern M; Itzkowitz S; Brown K
Am J Gastroenterol; 2002 Mar; 97(3):729-33. PubMed ID: 11922570
[TBL] [Abstract][Full Text] [Related]
11. Genetic testing in hereditary colorectal cancer: indications and procedures.
Terdiman JP; Conrad PG; Sleisenger MH
Am J Gastroenterol; 1999 Sep; 94(9):2344-56. PubMed ID: 10483990
[TBL] [Abstract][Full Text] [Related]
12. Screening for an inherited susceptibility to colorectal cancer.
Rowley PT
Genet Test; 2004; 8(4):421-30. PubMed ID: 15684875
[TBL] [Abstract][Full Text] [Related]
13. A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers.
Vasen HF; van Ballegooijen M; Buskens E; Kleibeuker JK; Taal BG; Griffioen G; Nagengast FM; Menko FH; Meera Khan P
Cancer; 1998 May; 82(9):1632-7. PubMed ID: 9576281
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness of a new strategy to identify HNPCC patients.
Kievit W; de Bruin JH; Adang EM; Severens JL; Kleibeuker JH; Sijmons RH; Ruers TJ; Nagengast FM; Vasen HF; van Krieken JH; Ligtenberg MJ; Hoogerbrugge N
Gut; 2005 Jan; 54(1):97-102. PubMed ID: 15591512
[TBL] [Abstract][Full Text] [Related]
16. Cohorts with familial disposition for colon cancers in chemoprevention trials.
Burt RW
J Cell Biochem Suppl; 1996; 25():131-5. PubMed ID: 9027609
[TBL] [Abstract][Full Text] [Related]
17. Prevention of colorectal cancer in high-risk populations: the increasing role for endoscopy and chemoprevention in FAP and HNPCC.
Lynch PM
Digestion; 2007; 76(1):68-76. PubMed ID: 17947820
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of surveillance programs for families at high and moderate risk of hereditary non-polyposis colorectal cancer.
Olsen KR; Bojesen SE; Gerdes AM; Lindorff-Larsen K; Bernstein IT
Int J Technol Assess Health Care; 2007; 23(1):89-95. PubMed ID: 17234021
[TBL] [Abstract][Full Text] [Related]
19. [Hereditary colorectal cancer].
Park JG; Kim IJ
Korean J Gastroenterol; 2005 Feb; 45(2):78-87. PubMed ID: 15725711
[TBL] [Abstract][Full Text] [Related]
20. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
